Glioblastoma Multiforme
Showing NaN - NaN of 21
Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)
Recruiting
- Glioblastoma Multiforme
- Retifanlimab
- +2 more
-
Baltimore, MarylandJohns Hopkins Medical Institution
Dec 5, 2022
Glioblastoma Multiforme Trial in Baltimore (Dichloroacetate (DCA), Genotype)
Recruiting
- Glioblastoma Multiforme
- Dichloroacetate (DCA)
- Genotype
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 26, 2022
Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)
Recruiting
- Glioblastoma Multiforme
- Recurrent Glioblastoma
- TheraSphere GBM
-
San Francisco, California
- +4 more
Aug 15, 2022
Glioblastoma Multiforme, Brain Tumors Trial in United States (OncoGel (ReGel/Paclitaxel))
Terminated
- Glioblastoma Multiforme
- Brain Neoplasms
- OncoGel (ReGel/Paclitaxel)
-
Chicago, Illinois
- +4 more
Jun 2, 2022
Glioblastoma Multiforme Trial in Washington, Baltimore (Temozolomide)
Completed
- Glioblastoma Multiforme
-
Washington, District of Columbia
- +2 more
Nov 17, 2021
Glioblastoma Multiforme Trial in Washington, Baltimore, Bethesda (Temozolomide, Subventricular Zone radiation, Neural Progenitor
Recruiting
- Glioblastoma Multiforme
- Temozolomide
- +2 more
-
Washington, District of Columbia
- +2 more
Sep 17, 2021
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Chicago, Baltimore, Saint Paul (PAC-1 Compound)
Suspended
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- PAC-1 Compound
-
Chicago, Illinois
- +2 more
Sep 18, 2020
Glioblastoma, Glioblastoma Multiforme Trial in Baltimore (Nivolumab, Anti-GITR Monoclonal Antibody MK-4166, IDO1 inhibitor
Terminated
- Glioblastoma
- Glioblastoma Multiforme
- Nivolumab
- +3 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Jun 30, 2020
Glioblastoma Multiforme Trial in Baltimore, Winston-Salem (Diet modification)
Completed
- Glioblastoma Multiforme
- Diet modification
-
Baltimore, Maryland
- +1 more
May 8, 2020
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Worldwide (Toca 511, Toca FC, Lomustine)
Terminated
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Toca 511
- +4 more
-
Phoenix, Arizona
- +66 more
Feb 6, 2020
Glioblastoma Multiforme Trial in Baltimore (Radiation, Chemotherapy)
Completed
- Glioblastoma Multiforme
- Radiation
- Chemotherapy
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 11, 2019
Glioblastoma Multiforme Trial in United States (poly ICLC, temozolomide, radiation therapy)
Completed
- Glioblastoma Multiforme
- poly ICLC
- +2 more
-
Birmingham, Alabama
- +8 more
May 30, 2019
Glioblastoma Multiforme Trial in Austria, Canada, United States (ICT-107, Placebo)
Suspended
- Glioblastoma Multiforme
- ICT-107
- Placebo
-
Birmingham, Alabama
- +64 more
Aug 9, 2018
Glioblastoma Multiforme Trial in Worldwide (NovoTTF-100A device, Temozolomide)
Completed
- Glioblastoma Multiforme
- NovoTTF-100A device
- Temozolomide
-
Birmingham, Alabama
- +88 more
Apr 7, 2017
Glioblastoma Multiforme Trial in United States (ICT-107, Placebo DC)
Completed
- Glioblastoma Multiforme
- ICT-107
- Placebo DC
-
South Birmingham, Alabama
- +24 more
Feb 10, 2017
Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (131-I-TM-601, 131I-TM601)
Unknown status
- Malignant Glioma
- +5 more
-
Birmingham, Alabama
- +18 more
Apr 1, 2009